United States: Radiation Oncology: What You Need To Know About The Long Awaited Bundled Payment Proposal

On July 10, 2019, the Centers for Medicare & Medicaid Services (CMS) and the Center for Medicare & Medicaid Innovation (Innovation Center) released a much awaited proposal for a new bundled payment model for radiation oncology. The Proposed Rule (Medicare Program; Specialty Care Models To Improve Quality of Care and Reduce Expenditures), which was published in the Federal Register on July 18, follows months of discussion concerning radiation oncology alternative payment models from leaders at CMS and the Department of Health and Human Services (HHS) and speculation in the oncology community. The deadline for comments on the Notice of Proposed Rule Making is September 16, 2019, at 5 p.m. ET.

According to CMS, the Radiation Oncology (RO) Model aims to address three problems identified by Congress under the Patient Access and Medicare Protection Act related to the provision of radiation oncology: lack of site neutrality for payments, incentives that encourage volume of services over value of services, and coding and payment challenges.

In a departure from the recent "opt-in" alternative payment models, the proposed RO Model would require participation from radiotherapy (RT) providers and suppliers that furnish RT services within randomly selected geographic areas, and apply prospective, episodic payments to physician group practices, hospital outpatient departments, and freestanding radiation therapy centers for radiotherapy services. Under the CMS Quality Payment Program, the model qualifies as an Advanced Alternative Payment Model (Advanced APM) and a Merit-based Incentive Payment System APM (MIPS APM).

The RO Model is proposed to begin in 2020 (either January 1 or April 1), and end December 31, 2024.

The Proposed Radiation Oncology Model's Key Features

The RO Model replaces the current fee-for-service payment system with prospective, episodic payments to incentivize higher-value radiotherapy care. Per CMS and the Innovation Center, the new model is defined by the following key elements:

  • Prospective, episodic (bundled) payments based on a patient's cancer diagnosis, covering a 90-day episode for the 17 cancer types meeting the model's included cancer type criteria;
  • Required participation for all providers in selected Core Based Statistical Areas (CBSAs);
  • Site-neutral payment, established through a common, adjusted, national base payment that applies regardless of the location at which services are furnished;
  • Split payments, into two components (professional and technical) in order to transition seamlessly into current claims systems; and
  • Linkage of payment to quality through reporting and performance on quality measures, clinical data reporting, and patient experience.

Participation in the Proposed Radiation Oncology Model

The required model participants will be radiotherapy providers and suppliers within randomly-selected CBSAs. The split-payment structure reflects these different participants: the professional component payment covers any included services that may only be furnished by a physician, and the technical component covers any included services not furnished by a physician (such as provision of equipment, supplies, personnel, and other costs).

Eligible RO Model participants include physician group practices, hospital outpatient departments, and freestanding radiation therapy centers. Participants will fall into one of three categories: Professional participants, Technical participants, and Dual participants.

  • A Professional participant is a physician practice group enrolled in Medicare, identified by a single Taxpayer Identification Number (TIN). Professional participants furnish only the professional component of radiotherapy services, either at a hospital outpatient department or at a freestanding radiation therapy center.
  • A Technical participant is a hospital outpatient department or freestanding radiation therapy center, identified by a single CMS Certification Number (CCN) or TIN. Technical participants furnish only the technical component of radiotherapy services.
  • A Dual participant may only furnish services through a freestanding radiation therapy center, identified by a single TIN. Dual participants furnish both the professional component and the technical component of radiotherapy services.

The proposed rule lists the following criteria for included cancer types: (1) the cancer type is commonly treated with radiation, and (2) the cancer type has associated current ICD-10 codes that have demonstrated pricing stability. At this time, CMS has identified seventeen (17) cancer types that fit these criteria: anal cancer, bladder cancer, bone metastases, brain metastases, breast cancer, cervical cancer, CNS tumors, colorectal cancer, head and neck cancer, kidney cancer, liver cancer, lung cancer, lymphoma, pancreatic cancer, prostate cancer, upper GI cancer, and uterine cancer.

Payment Under the Proposed Radiation Oncology Model

Under the RO Model, participant-specific payment amounts will be calculated considering the following factors: proposed national base rates, trend factors, and adjustments for the participant's case-mix, historical experience, and geographic location. A discount factor will then be applied at four percent (4%) for the professional component and five percent (5%) for the technical component. Additional withholds may then be applied: two percent (2%) for both the professional and technical components with respect to incomplete episodes, two percent (2%) for the professional component with respect to quality, and one percent (1%) for the technical component starting in 2022 with respect to beneficiary experience. Portions of the withholds can be earned back based on clinical data reporting, quality measure reporting and performance, and the Consumer Assessment of Healthcare Providers and Systems (CAHPS®) Cancer Care Radiation Therapy Survey.

Quality Programs

The RO Model will be an Advanced APM and a MIPS APM. RO Model participants that meet the Qualifying APM Participant (QP) threshold will qualify for the Advanced APM; otherwise, participants will be in a MIPS APM. Accordingly, participants are required to meet all pertinent requirements for their respective APMs. In addition, annual certification of intent to use Certified Electronic Health Record Technology will be required by all RO Model participants.

Role of Beneficiaries

Professional RO Model participants will be required to provide a RO Model Beneficiary Notification Letter to the Medicare beneficiaries that they treat. Beneficiaries will remain responsible for the cost-sharing requirements for which they were responsible under the traditional fee-for-service programs. However, beneficiary cost-sharing may be lower relative to traditional fee-for-service cost-sharing due to the discounts applied to the RO Model components.


The Radiation Oncology Model expands CMS's shift from traditional fee-for-service payment models into more quality-focused payment programs. The RO Model will introduce participants (physician practice groups, hospital outpatient departments, and freestanding radiation therapy centers in certain CBSAs) to prospective, episodic payments covering 90-day periods. Payments are split into professional and technical components, with different adjustments associated with each. The Model qualifies as an Advanced APM as well as a MIPS APM, and it provides the opportunity to increase payments based on clinical data reporting and quality measures and performance. This is the first mandatory payment model we have seen under the current administration, and we expect to see additional mandatory models behind it.

As comments are likely to be coming in from multiple sources, we anticipate further refinement of this draft guidance by CMS. Comments are likely to focus on implementation challenges, such as defining the proposed beneficiary population and cost-sharing implications. Technical legal issues will also need to be addressed to facilitate data sharing and permit revenue sharing under applicable fraud and abuse laws.

The deadline for comments on the Notice of Proposed Rule Making is September 16, 2019, at 5 p.m. ET. We are currently developing comments in response to the proposed rule, including the mandatory nature of the model.

Learn More at the ACCC Annual Meeting & Cancer Center Business Summit

The proposed model, and strategies for participation, minimizing the potential impact, and best practices in implementation, will be addressed at the Association for Community Cancer Centers (ACCC) 46th Annual Meeting & Cancer Center Business Summit (CCBS) to be held from March 4-6, 2020, at the Washington Hilton Hotel. Visit our website to learn more.

Stephanie Schwartz, Summer Associate, also contributed to the creation of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Akin Gump Strauss Hauer & Feld LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Akin Gump Strauss Hauer & Feld LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions